Dr Keith Lim

Consultant and Education Director, Department of Radiation Oncology, National University Cancer Institute, Singapore

After graduating from the National University of Singapore, Dr Keith Lim obtained his fellowship from the Royal Australian, New Zealand College of Radiology (RANZCR) at National University Hospital and at the Liverpool Hospital in Sydney. He is a graduate of the European Society of Radiotherapy and Oncology school of brachytherapy and completed his training in high dose rate brachytherapy at the University of California, San Francisco. Dr Lim’s sub-specialty interests are in breast, central nervous system and prostate cancer, where he has pioneered the use of high dose rate prostate brachytherapy in Singapore. He has published in peer reviewed journals, written book chapters and has been awarded $2 million dollars in competitive grant funding as either principal investigator or co-investigator. Dr Lim is the Director of Training for radiation oncology for the National University Cancer Institute, Singapore and is a member of Training Networks Directors Committee for the Royal Australian, New Zealand College of Radiology as well as the Residency Advisor Committee for Radiation Oncology. Dr Lim is an active member of numerous professional societies and was the vice-president of the Singapore Society of Oncologists from 2008 to 2010.

Education and Fellowships

MBBS FRANZCR

Specialty Interests

• Breast cancer
• Central nervous system cancer

• Genitourinary system cancer

 

Grants Awarded

• To Investigate The Effectiveness of zinc Supplementation In Patients With Advanced Non Small Cell Lung Cancer Treated With Palliative Radiotherapy; Can Lipid Oxidation Products Be Used To Predict Which Patients Will Benefit? National Medical Research Council (NMRC) Grant. Awarded 2011 $771,862.80. PI
• The Quantification And Physiological Function Of Ergothioneine In Vivo. National Medical Research Council (NMRC) Grant. Awarded 2010 $1,078,000. Co-I
• Does Cytokine Expression Correlate With Volume Of Tissue Irradiate And Dose Delivered In Patients Undergoing Radiotherapy For Prostate Cancer? National University Cancer Institute Singapore Centre Grant Pilot Grant. Awarded 2010 $40,000. PI
• Using Dynamic Contrast Enhanced CT Perfusion (CTP) To Predict And Measure Response To Radiation Therapy For Cerebral Metastases. National Medical Research Council (NMRC) Grant. Awarded 2008 $273,000. Co-PI
• Establishing A Predictive Model For Treatment Planning And Outcome In Nasopharyngeal Carcinoma: Refining The Current Staging System. The Cancer Institute Endowment Fund Grant. Awarded 2007 $27,000. Co-PI
• NUHS Leadership in Academic Medicine (NLAM) Mentoring Programme, mentoring grant. Awarded 2009 $2,000.

 

Selected Publications

1. Lim KHC, Lee CYJ, Earnest A. Does radiotherapy increase oxidative stress? A study with nasopharyngeal cancer patients revealing anomalies in isoprostanes measurements. Accepted FRR May 21, 2010.
   
2. Shakespeare TP, Lim KHC, Lee KM, Lu JJ, Mukherjee R and Back MF. Phase II study of the American Brachytherapy Society guidelines for the use of high dose rate (HDR) brachytherapy in the treatment of cervical carcinoma: is 45-50.4Gy radiochemotherapy plus 31.8Gy in 6 fractions HDR brachytherapy tolerable? Int J Gynecol Cancer. 2006; 16(1):277-82.
   
3. Lim KHC, Back MF, Lu JJ, Wynne CJ, Shakespeare TP. A Study of Complications Arising from Different Methods of Analgesia Used in Brachytherapy for Cervical Cancer. American Journal of Clinical Oncology. 2004; 27(5):449-451.
   
4. Leong C, Shakespeare TP, Mukherjee R, Back MF, Lee K, Lu JJ, Wynne CJ, Lim K, Tang J, Zhang X. Effect of an integrated continuing medical education (CME) and Quality Improvement (QI) program on radiation oncologist (RO) clinical practice. Int J Radiation Oncol Biol Phys. 2004; 60(1): S555-556.
   
5. Shakespeare TP, Gebski V, Tang J, Lim K. Does result presentation influence physician interpretation of published research? Analysis of the Primer 1 randomized study. Ann Acad Med Sing. 2004; 33(5): S109.
   
6. Shakespeare TP, Zhang XJ, Gebski V, Tang J, Lim K, Lu JJ, Jiang G. Improving the interpretation of clinical research by oncologists: results of the PRIMER randomised study. Ann Acad Med Sing. 2004; 33(5): S109.
   
7. Shakespeare TP, Gebski V, Tang J, Lim K, Lu JJ, Zhang X, Jiang G. Influence of the Way Results Are Presented on Research Interpretation and Medical Decision Making: The PRIMER Collaboration Randomized Studies. Med Decis Making. 2008; 28(1):127-37.